Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SAVA Cassava Sciences Inc

30.73

0.41 (1.35%)

Last Updated: 09:44:09

Delayed by 15 minutes

Cassava Sciences outlines Pivotal Phase 3 trial design for Simufilam in Alzheimer’s

To read the full story on Seeking Alpha, click here.

Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Aug 2024 to Sep 2024

Click Here for more Cassava Sciences Charts.

Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Sep 2023 to Sep 2024

Click Here for more Cassava Sciences Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Cassava Sciences Inc News

More Cassava Sciences Inc News Articles

TransCode Therapeutics

Impact Fusion (PK)

Brookmount Explorations (PK)

Branded Legacy (PK)

NaturalShrimp (QB)

Valiant Eagle (PK)

Enzolytics (PK)

CyberFuels (PK)

1812 Brewing (PK)

Hannover House (PK)

ERHC Energy (CE)

RespireRx Pharmaceuticals (CE)

Delayed Upgrade Clock